Hospital Injectable Drugs Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Generic Sterile Injectables
1.2.3 Sterile Intravenous (IV) Solutions
1.3 Market by Application
1.3.1 Global Hospital Injectable Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital Injectable Drugs Market Perspective (2017-2028)
2.2 Hospital Injectable Drugs Growth Trends by Region
2.2.1 Hospital Injectable Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hospital Injectable Drugs Historic Market Size by Region (2017-2022)
2.2.3 Hospital Injectable Drugs Forecasted Market Size by Region (2023-2028)
2.3 Hospital Injectable Drugs Market Dynamics
2.3.1 Hospital Injectable Drugs Industry Trends
2.3.2 Hospital Injectable Drugs Market Drivers
2.3.3 Hospital Injectable Drugs Market Challenges
2.3.4 Hospital Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Injectable Drugs Players by Revenue
3.1.1 Global Top Hospital Injectable Drugs Players by Revenue (2017-2022)
3.1.2 Global Hospital Injectable Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Injectable Drugs Revenue
3.4 Global Hospital Injectable Drugs Market Concentration Ratio
3.4.1 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2021
3.5 Hospital Injectable Drugs Key Players Head office and Area Served
3.6 Key Players Hospital Injectable Drugs Product Solution and Service
3.7 Date of Enter into Hospital Injectable Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Injectable Drugs Breakdown Data by Type
4.1 Global Hospital Injectable Drugs Historic Market Size by Type (2017-2022)
4.2 Global Hospital Injectable Drugs Forecasted Market Size by Type (2023-2028)
5 Hospital Injectable Drugs Breakdown Data by Application
5.1 Global Hospital Injectable Drugs Historic Market Size by Application (2017-2022)
5.2 Global Hospital Injectable Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hospital Injectable Drugs Market Size (2017-2028)
6.2 North America Hospital Injectable Drugs Market Size by Type
6.2.1 North America Hospital Injectable Drugs Market Size by Type (2017-2022)
6.2.2 North America Hospital Injectable Drugs Market Size by Type (2023-2028)
6.2.3 North America Hospital Injectable Drugs Market Share by Type (2017-2028)
6.3 North America Hospital Injectable Drugs Market Size by Application
6.3.1 North America Hospital Injectable Drugs Market Size by Application (2017-2022)
6.3.2 North America Hospital Injectable Drugs Market Size by Application (2023-2028)
6.3.3 North America Hospital Injectable Drugs Market Share by Application (2017-2028)
6.4 North America Hospital Injectable Drugs Market Size by Country
6.4.1 North America Hospital Injectable Drugs Market Size by Country (2017-2022)
6.4.2 North America Hospital Injectable Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Hospital Injectable Drugs Market Size (2017-2028)
7.2 Europe Hospital Injectable Drugs Market Size by Type
7.2.1 Europe Hospital Injectable Drugs Market Size by Type (2017-2022)
7.2.2 Europe Hospital Injectable Drugs Market Size by Type (2023-2028)
7.2.3 Europe Hospital Injectable Drugs Market Share by Type (2017-2028)
7.3 Europe Hospital Injectable Drugs Market Size by Application
7.3.1 Europe Hospital Injectable Drugs Market Size by Application (2017-2022)
7.3.2 Europe Hospital Injectable Drugs Market Size by Application (2023-2028)
7.3.3 Europe Hospital Injectable Drugs Market Share by Application (2017-2028)
7.4 Europe Hospital Injectable Drugs Market Size by Country
7.4.1 Europe Hospital Injectable Drugs Market Size by Country (2017-2022)
7.4.2 Europe Hospital Injectable Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Injectable Drugs Market Size (2017-2028)
8.2 Asia-Pacific Hospital Injectable Drugs Market Size by Type
8.2.1 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hospital Injectable Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Hospital Injectable Drugs Market Size by Application
8.3.1 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hospital Injectable Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Hospital Injectable Drugs Market Size by Region
8.4.1 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hospital Injectable Drugs Market Size (2017-2028)
9.2 Latin America Hospital Injectable Drugs Market Size by Type
9.2.1 Latin America Hospital Injectable Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Hospital Injectable Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Hospital Injectable Drugs Market Share by Type (2017-2028)
9.3 Latin America Hospital Injectable Drugs Market Size by Application
9.3.1 Latin America Hospital Injectable Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Hospital Injectable Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Hospital Injectable Drugs Market Share by Application (2017-2028)
9.4 Latin America Hospital Injectable Drugs Market Size by Country
9.4.1 Latin America Hospital Injectable Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Hospital Injectable Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Injectable Drugs Market Size (2017-2028)
10.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type
10.2.1 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hospital Injectable Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Hospital Injectable Drugs Market Size by Application
10.3.1 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hospital Injectable Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Hospital Injectable Drugs Market Size by Country
10.4.1 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Details
11.1.2 Hospira (Pfizer Inc.) Business Overview
11.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Introduction
11.1.4 Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2017-2022)
11.1.5 Hospira (Pfizer Inc.) Recent Developments
11.2 Baxter
11.2.1 Baxter Company Details
11.2.2 Baxter Business Overview
11.2.3 Baxter Hospital Injectable Drugs Introduction
11.2.4 Baxter Revenue in Hospital Injectable Drugs Business (2017-2022)
11.2.5 Baxter Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Details
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Hospital Injectable Drugs Introduction
11.3.4 Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2017-2022)
11.3.5 Fresenius Kabi Recent Developments
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Details
11.4.2 Sandoz (Novartis) Business Overview
11.4.3 Sandoz (Novartis) Hospital Injectable Drugs Introduction
11.4.4 Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2017-2022)
11.4.5 Sandoz (Novartis) Recent Developments
11.5 Hikma Pharmaceuticals PLC
11.5.1 Hikma Pharmaceuticals PLC Company Details
11.5.2 Hikma Pharmaceuticals PLC Business Overview
11.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Introduction
11.5.4 Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2017-2022)
11.5.5 Hikma Pharmaceuticals PLC Recent Developments
11.6 Dr. Reddy?s Laboratories Ltd
11.6.1 Dr. Reddy?s Laboratories Ltd Company Details
11.6.2 Dr. Reddy?s Laboratories Ltd Business Overview
11.6.3 Dr. Reddy?s Laboratories Ltd Hospital Injectable Drugs Introduction
11.6.4 Dr. Reddy?s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2017-2022)
11.6.5 Dr. Reddy?s Laboratories Ltd Recent Developments
11.7 Grifols
11.7.1 Grifols Company Details
11.7.2 Grifols Business Overview
11.7.3 Grifols Hospital Injectable Drugs Introduction
11.7.4 Grifols Revenue in Hospital Injectable Drugs Business (2017-2022)
11.7.5 Grifols Recent Developments
11.8 Nichi-Iko Group (Sagent)
11.8.1 Nichi-Iko Group (Sagent) Company Details
11.8.2 Nichi-Iko Group (Sagent) Business Overview
11.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Introduction
11.8.4 Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2017-2022)
11.8.5 Nichi-Iko Group (Sagent) Recent Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Hospital Injectable Drugs Introduction
11.9.4 Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
11.9.5 Teva Pharmaceutical Recent Developments
11.10 Otsuka
11.10.1 Otsuka Company Details
11.10.2 Otsuka Business Overview
11.10.3 Otsuka Hospital Injectable Drugs Introduction
11.10.4 Otsuka Revenue in Hospital Injectable Drugs Business (2017-2022)
11.10.5 Otsuka Recent Developments
11.11 B.Braun
11.11.1 B.Braun Company Details
11.11.2 B.Braun Business Overview
11.11.3 B.Braun Hospital Injectable Drugs Introduction
11.11.4 B.Braun Revenue in Hospital Injectable Drugs Business (2017-2022)
11.11.5 B.Braun Recent Developments
11.12 JW Life Science
11.12.1 JW Life Science Company Details
11.12.2 JW Life Science Business Overview
11.12.3 JW Life Science Hospital Injectable Drugs Introduction
11.12.4 JW Life Science Revenue in Hospital Injectable Drugs Business (2017-2022)
11.12.5 JW Life Science Recent Developments
11.13 Auromedics
11.13.1 Auromedics Company Details
11.13.2 Auromedics Business Overview
11.13.3 Auromedics Hospital Injectable Drugs Introduction
11.13.4 Auromedics Revenue in Hospital Injectable Drugs Business (2017-2022)
11.13.5 Auromedics Recent Developments
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Hospital Injectable Drugs Introduction
11.14.4 Sanofi Revenue in Hospital Injectable Drugs Business (2017-2022)
11.14.5 Sanofi Recent Developments
11.15 Gland Pharma
11.15.1 Gland Pharma Company Details
11.15.2 Gland Pharma Business Overview
11.15.3 Gland Pharma Hospital Injectable Drugs Introduction
11.15.4 Gland Pharma Revenue in Hospital Injectable Drugs Business (2017-2022)
11.15.5 Gland Pharma Recent Developments
11.16 Endo International PLC
11.16.1 Endo International PLC Company Details
11.16.2 Endo International PLC Business Overview
11.16.3 Endo International PLC Hospital Injectable Drugs Introduction
11.16.4 Endo International PLC Revenue in Hospital Injectable Drugs Business (2017-2022)
11.16.5 Endo International PLC Recent Developments
11.17 Sichuan Kelun Pharmaceutical
11.17.1 Sichuan Kelun Pharmaceutical Company Details
11.17.2 Sichuan Kelun Pharmaceutical Business Overview
11.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Introduction
11.17.4 Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
11.17.5 Sichuan Kelun Pharmaceutical Recent Developments
11.18 Cisen Pharmaceutical
11.18.1 Cisen Pharmaceutical Company Details
11.18.2 Cisen Pharmaceutical Business Overview
11.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Introduction
11.18.4 Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
11.18.5 Cisen Pharmaceutical Recent Developments
11.19 Shijiazhuang No. 4 Pharmaceutical
11.19.1 Shijiazhuang No. 4 Pharmaceutical Company Details
11.19.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
11.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Introduction
11.19.4 Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
11.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Developments
11.20 Shandong Hualu Pharmaceutical
11.20.1 Shandong Hualu Pharmaceutical Company Details
11.20.2 Shandong Hualu Pharmaceutical Business Overview
11.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Introduction
11.20.4 Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
11.20.5 Shandong Hualu Pharmaceutical Recent Developments
11.21 CR Double-Crane
11.21.1 CR Double-Crane Company Details
11.21.2 CR Double-Crane Business Overview
11.21.3 CR Double-Crane Hospital Injectable Drugs Introduction
11.21.4 CR Double-Crane Revenue in Hospital Injectable Drugs Business (2017-2022)
11.21.5 CR Double-Crane Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hospital Injectable Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Generic Sterile Injectables
Table 3. Key Players of Sterile Intravenous (IV) Solutions
Table 4. Global Hospital Injectable Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Hospital Injectable Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Hospital Injectable Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Hospital Injectable Drugs Market Share by Region (2017-2022)
Table 8. Global Hospital Injectable Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Hospital Injectable Drugs Market Share by Region (2023-2028)
Table 10. Hospital Injectable Drugs Market Trends
Table 11. Hospital Injectable Drugs Market Drivers
Table 12. Hospital Injectable Drugs Market Challenges
Table 13. Hospital Injectable Drugs Market Restraints
Table 14. Global Hospital Injectable Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Hospital Injectable Drugs Revenue Share by Players (2017-2022)
Table 16. Global Top Hospital Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Injectable Drugs as of 2021)
Table 17. Ranking of Global Top Hospital Injectable Drugs Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Hospital Injectable Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hospital Injectable Drugs Product Solution and Service
Table 21. Date of Enter into Hospital Injectable Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Hospital Injectable Drugs Revenue Market Share by Type (2017-2022)
Table 25. Global Hospital Injectable Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Hospital Injectable Drugs Revenue Market Share by Type (2023-2028)
Table 27. Global Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Hospital Injectable Drugs Revenue Share by Application (2017-2022)
Table 29. Global Hospital Injectable Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Hospital Injectable Drugs Revenue Share by Application (2023-2028)
Table 31. North America Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Hospital Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Hospital Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Hospital Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Hospital Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Hospital Injectable Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Hospital Injectable Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Hospital Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Hospital Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Hospital Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Hospital Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 61. Hospira (Pfizer Inc.) Company Details
Table 62. Hospira (Pfizer Inc.) Business Overview
Table 63. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product
Table 64. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 65. Hospira (Pfizer Inc.) Recent Developments
Table 66. Baxter Company Details
Table 67. Baxter Business Overview
Table 68. Baxter Hospital Injectable Drugs Product
Table 69. Baxter Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 70. Baxter Recent Developments
Table 71. Fresenius Kabi Company Details
Table 72. Fresenius Kabi Business Overview
Table 73. Fresenius Kabi Hospital Injectable Drugs Product
Table 74. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 75. Fresenius Kabi Recent Developments
Table 76. Sandoz (Novartis) Company Details
Table 77. Sandoz (Novartis) Business Overview
Table 78. Sandoz (Novartis) Hospital Injectable Drugs Product
Table 79. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 80. Sandoz (Novartis) Recent Developments
Table 81. Hikma Pharmaceuticals PLC Company Details
Table 82. Hikma Pharmaceuticals PLC Business Overview
Table 83. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product
Table 84. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 85. Hikma Pharmaceuticals PLC Recent Developments
Table 86. Dr. Reddy?s Laboratories Ltd Company Details
Table 87. Dr. Reddy?s Laboratories Ltd Business Overview
Table 88. Dr. Reddy?s Laboratories Ltd Hospital Injectable Drugs Product
Table 89. Dr. Reddy?s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 90. Dr. Reddy?s Laboratories Ltd Recent Developments
Table 91. Grifols Company Details
Table 92. Grifols Business Overview
Table 93. Grifols Hospital Injectable Drugs Product
Table 94. Grifols Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 95. Grifols Recent Developments
Table 96. Nichi-Iko Group (Sagent) Company Details
Table 97. Nichi-Iko Group (Sagent) Business Overview
Table 98. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product
Table 99. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 100. Nichi-Iko Group (Sagent) Recent Developments
Table 101. Teva Pharmaceutical Company Details
Table 102. Teva Pharmaceutical Business Overview
Table 103. Teva Pharmaceutical Hospital Injectable Drugs Product
Table 104. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 105. Teva Pharmaceutical Recent Developments
Table 106. Otsuka Company Details
Table 107. Otsuka Business Overview
Table 108. Otsuka Hospital Injectable Drugs Product
Table 109. Otsuka Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 110. Otsuka Recent Developments
Table 111. B.Braun Company Details
Table 112. B.Braun Business Overview
Table 113. B.Braun Hospital Injectable Drugs Product
Table 114. B.Braun Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 115. B.Braun Recent Developments
Table 116. JW Life Science Company Details
Table 117. JW Life Science Business Overview
Table 118. JW Life Science Hospital Injectable Drugs Product
Table 119. JW Life Science Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 120. JW Life Science Recent Developments
Table 121. Auromedics Company Details
Table 122. Auromedics Business Overview
Table 123. Auromedics Hospital Injectable Drugs Product
Table 124. Auromedics Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 125. Auromedics Recent Developments
Table 126. Sanofi Company Details
Table 127. Sanofi Business Overview
Table 128. Sanofi Hospital Injectable Drugs Product
Table 129. Sanofi Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 130. Sanofi Recent Developments
Table 131. Gland Pharma Company Details
Table 132. Gland Pharma Business Overview
Table 133. Gland Pharma Hospital Injectable Drugs Product
Table 134. Gland Pharma Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 135. Gland Pharma Recent Developments
Table 136. Endo International PLC Company Details
Table 137. Endo International PLC Business Overview
Table 138. Endo International PLC Hospital Injectable Drugs Product
Table 139. Endo International PLC Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 140. Endo International PLC Recent Developments
Table 141. Sichuan Kelun Pharmaceutical Company Details
Table 142. Sichuan Kelun Pharmaceutical Business Overview
Table 143. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product
Table 144. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 145. Sichuan Kelun Pharmaceutical Recent Developments
Table 146. Cisen Pharmaceutical Company Details
Table 147. Cisen Pharmaceutical Business Overview
Table 148. Cisen Pharmaceutical Hospital Injectable Drugs Product
Table 149. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 150. Cisen Pharmaceutical Recent Developments
Table 151. Shijiazhuang No. 4 Pharmaceutical Company Details
Table 152. Shijiazhuang No. 4 Pharmaceutical Business Overview
Table 153. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product
Table 154. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 155. Shijiazhuang No. 4 Pharmaceutical Recent Developments
Table 156. Shandong Hualu Pharmaceutical Company Details
Table 157. Shandong Hualu Pharmaceutical Business Overview
Table 158. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product
Table 159. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 160. Shandong Hualu Pharmaceutical Recent Developments
Table 161. CR Double-Crane Company Details
Table 162. CR Double-Crane Business Overview
Table 163. CR Double-Crane Hospital Injectable Drugs Product
Table 164. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
Table 165. CR Double-Crane Recent Developments
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Injectable Drugs Market Share by Type: 2021 VS 2028
Figure 2. Generic Sterile Injectables Features
Figure 3. Sterile Intravenous (IV) Solutions Features
Figure 4. Global Hospital Injectable Drugs Market Share by Application: 2021 VS 2028
Figure 5. Oncology Case Studies
Figure 6. Anesthesia Case Studies
Figure 7. Anti-Infectives Case Studies
Figure 8. Parenteral Nutrition Case Studies
Figure 9. Cardiovascular Diseases Case Studies
Figure 10. Hospital Injectable Drugs Report Years Considered
Figure 11. Global Hospital Injectable Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Hospital Injectable Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Hospital Injectable Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global Hospital Injectable Drugs Market Share by Players in 2021
Figure 15. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Injectable Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2021
Figure 17. North America Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 19. North America Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 20. North America Hospital Injectable Drugs Market Size Share by Country (2017-2028)
Figure 21. United States Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 25. Europe Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 26. Europe Hospital Injectable Drugs Market Size Share by Country (2017-2028)
Figure 27. Germany Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Hospital Injectable Drugs Market Size Share by Region (2017-2028)
Figure 37. China Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Hospital Injectable Drugs Market Size Share by Country (2017-2028)
Figure 47. Mexico Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Hospital Injectable Drugs Market Size Share by Country (2017-2028)
Figure 53. Turkey Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Hospira (Pfizer Inc.) Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 57. Baxter Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 58. Fresenius Kabi Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 59. Sandoz (Novartis) Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 60. Hikma Pharmaceuticals PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 61. Dr. Reddy?s Laboratories Ltd Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 62. Grifols Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 63. Nichi-Iko Group (Sagent) Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 65. Otsuka Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 66. B.Braun Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 67. JW Life Science Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 68. Auromedics Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 69. Sanofi Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 70. Gland Pharma Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 71. Endo International PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 72. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 73. Cisen Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 74. Shijiazhuang No. 4 Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 75. Shandong Hualu Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 76. CR Double-Crane Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Industry Market Size
